46
Participants
Start Date
February 28, 2014
Primary Completion Date
November 2, 2017
Study Completion Date
November 2, 2017
aflibercept
"1. Three monthly intravitreal aflibercept (2mg) injections~2. Five bimonthly intravitreal aflibercept (2mg) injections~3. Rescue treatment: Verteporfin photodynamic therapy~ * Loss of five ETDRS letters or one Snellen line of vision from baseline~ * Presence of subretinal fluid or intraretinal fluid despite three consecutive (monthly or bimonthly) aflibercept injection~ * Presence of active polyp on indocyanine green angiography"
Seoul National University Bundang Hospital, Seongnam
Konyang University Kim's Eye Hospital, Seoul
Samsung Medical Center, Seoul
Collaborators (1)
Seoul National University Bundang Hospital
OTHER
Kim's Eye Hospital
OTHER
Bayer
INDUSTRY
Samsung Medical Center
OTHER